Expression and shedding of endothelial protein C receptor in prostate cancer cells

<p>Abstract</p> <p>Background</p> <p>Increasing evidences show that beyond its role in coagulation, endothelial protein C receptor (EPCR) interferes with carcinogenesis. Pro-carcinogenic effects of EPCR were linked with a raised generation of activated protein C (aPC) a...

Full description

Bibliographic Details
Main Authors: Eisenhofer Graeme, Klinsmann Ludwig, Tiebel Oliver, Hagelgans Albert, Menschikowski Mario, Siegert Gabriele
Format: Article
Language:English
Published: BMC 2011-02-01
Series:Cancer Cell International
Online Access:http://www.cancerci.com/content/11/1/4
_version_ 1811260069498585088
author Eisenhofer Graeme
Klinsmann Ludwig
Tiebel Oliver
Hagelgans Albert
Menschikowski Mario
Siegert Gabriele
author_facet Eisenhofer Graeme
Klinsmann Ludwig
Tiebel Oliver
Hagelgans Albert
Menschikowski Mario
Siegert Gabriele
author_sort Eisenhofer Graeme
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Increasing evidences show that beyond its role in coagulation, endothelial protein C receptor (EPCR) interferes with carcinogenesis. Pro-carcinogenic effects of EPCR were linked with a raised generation of activated protein C (aPC) and anti-apoptotic signalling. This study was carried out to analyze the expression, cell surface exposition, and shedding of EPCR in normal and malignant prostate cell lines.</p> <p>Results</p> <p>EPCR expression is up-regulated both at the mRNA and protein levels in invasive prostate DU-145 and PC-3 cells in comparison to normal prostate epithelial cells (PrEC) and less-invasive LNCaP cells. Release of soluble EPCR (sEPCR) is induced by 12-myristate 13-acetate, ionomycin, H<sub>2</sub>O<sub>2</sub>, and disruptor of lipid rafts in PrEC, DU-145, and PC-3 cells. Furthermore, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), but not interleukin-6 or interferon-γ increase sEPCR release. In LNCaP cells, neither pharmacological agents nor IL-1β or TNF-α result in a significant increase of sEPCR release. The effects of IL-1β and TNF-α on EPCR shedding in DU-145 cells are mediated by MEK/ERK 1/2, JNK, and p38 MAPK signalling cascades. In PC-3 cells, however, the MEK/ERK 1/2 pathway is down-regulated and incubation with cytokines did not elevate the phosphorylated ERK-1/2 fraction as in the case of DU-145 cells. Treatment with 4-aminophenylmercuric acetate (APMA), an activator of metalloproteases, causes a disproportionately large increase of sEPCR release in DU-145 and PC-3 cells, compared to PrEC and LNCaP cells. Finally, an increased release of sEPCR mediated by APMA treatment is shown to be connected with reduced generation of activated protein C indicating the functionality of EPCR in these cells.</p> <p>Conclusions</p> <p>The study demonstrates a number of substantial differences in expression and shedding of EPCR in prostate cancer cell lines in comparison with normal cells that may be relevant for understanding the role of this receptor in carcinogenesis.</p>
first_indexed 2024-04-12T18:40:59Z
format Article
id doaj.art-e191dc128ec948d69d95aebbba3bc90a
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-12T18:40:59Z
publishDate 2011-02-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-e191dc128ec948d69d95aebbba3bc90a2022-12-22T03:20:46ZengBMCCancer Cell International1475-28672011-02-01111410.1186/1475-2867-11-4Expression and shedding of endothelial protein C receptor in prostate cancer cellsEisenhofer GraemeKlinsmann LudwigTiebel OliverHagelgans AlbertMenschikowski MarioSiegert Gabriele<p>Abstract</p> <p>Background</p> <p>Increasing evidences show that beyond its role in coagulation, endothelial protein C receptor (EPCR) interferes with carcinogenesis. Pro-carcinogenic effects of EPCR were linked with a raised generation of activated protein C (aPC) and anti-apoptotic signalling. This study was carried out to analyze the expression, cell surface exposition, and shedding of EPCR in normal and malignant prostate cell lines.</p> <p>Results</p> <p>EPCR expression is up-regulated both at the mRNA and protein levels in invasive prostate DU-145 and PC-3 cells in comparison to normal prostate epithelial cells (PrEC) and less-invasive LNCaP cells. Release of soluble EPCR (sEPCR) is induced by 12-myristate 13-acetate, ionomycin, H<sub>2</sub>O<sub>2</sub>, and disruptor of lipid rafts in PrEC, DU-145, and PC-3 cells. Furthermore, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), but not interleukin-6 or interferon-γ increase sEPCR release. In LNCaP cells, neither pharmacological agents nor IL-1β or TNF-α result in a significant increase of sEPCR release. The effects of IL-1β and TNF-α on EPCR shedding in DU-145 cells are mediated by MEK/ERK 1/2, JNK, and p38 MAPK signalling cascades. In PC-3 cells, however, the MEK/ERK 1/2 pathway is down-regulated and incubation with cytokines did not elevate the phosphorylated ERK-1/2 fraction as in the case of DU-145 cells. Treatment with 4-aminophenylmercuric acetate (APMA), an activator of metalloproteases, causes a disproportionately large increase of sEPCR release in DU-145 and PC-3 cells, compared to PrEC and LNCaP cells. Finally, an increased release of sEPCR mediated by APMA treatment is shown to be connected with reduced generation of activated protein C indicating the functionality of EPCR in these cells.</p> <p>Conclusions</p> <p>The study demonstrates a number of substantial differences in expression and shedding of EPCR in prostate cancer cell lines in comparison with normal cells that may be relevant for understanding the role of this receptor in carcinogenesis.</p>http://www.cancerci.com/content/11/1/4
spellingShingle Eisenhofer Graeme
Klinsmann Ludwig
Tiebel Oliver
Hagelgans Albert
Menschikowski Mario
Siegert Gabriele
Expression and shedding of endothelial protein C receptor in prostate cancer cells
Cancer Cell International
title Expression and shedding of endothelial protein C receptor in prostate cancer cells
title_full Expression and shedding of endothelial protein C receptor in prostate cancer cells
title_fullStr Expression and shedding of endothelial protein C receptor in prostate cancer cells
title_full_unstemmed Expression and shedding of endothelial protein C receptor in prostate cancer cells
title_short Expression and shedding of endothelial protein C receptor in prostate cancer cells
title_sort expression and shedding of endothelial protein c receptor in prostate cancer cells
url http://www.cancerci.com/content/11/1/4
work_keys_str_mv AT eisenhofergraeme expressionandsheddingofendothelialproteincreceptorinprostatecancercells
AT klinsmannludwig expressionandsheddingofendothelialproteincreceptorinprostatecancercells
AT tiebeloliver expressionandsheddingofendothelialproteincreceptorinprostatecancercells
AT hagelgansalbert expressionandsheddingofendothelialproteincreceptorinprostatecancercells
AT menschikowskimario expressionandsheddingofendothelialproteincreceptorinprostatecancercells
AT siegertgabriele expressionandsheddingofendothelialproteincreceptorinprostatecancercells